Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pitx2
|
ENSMUSG00000028023.10 | paired-like homeodomain transcription factor 2 |
Otx2
|
ENSMUSG00000021848.9 | orthodenticle homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_48667515_48667667 | Otx2 | 53 | 0.925627 | 0.77 | 7.3e-12 | Click! |
chr14_48666180_48666367 | Otx2 | 752 | 0.428731 | 0.71 | 1.2e-09 | Click! |
chr14_48665335_48665486 | Otx2 | 111 | 0.920994 | 0.66 | 3.5e-08 | Click! |
chr14_48665025_48665185 | Otx2 | 1 | 0.947670 | 0.63 | 3.0e-07 | Click! |
chr3_129200004_129200202 | Pitx2 | 134 | 0.957304 | 0.73 | 3.8e-10 | Click! |
chr3_129199429_129199931 | Pitx2 | 198 | 0.936788 | 0.69 | 7.3e-09 | Click! |
chr3_129204151_129204986 | Pitx2 | 621 | 0.696278 | 0.68 | 9.4e-09 | Click! |
chr3_129200277_129200428 | Pitx2 | 383 | 0.846222 | 0.68 | 1.4e-08 | Click! |
chr3_129205035_129205234 | Pitx2 | 1187 | 0.438961 | 0.66 | 3.9e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_20616739_20617639 | 73.37 |
Gm16090 |
predicted gene 16090 |
48071 |
0.1 |
chr18_20621651_20622570 | 66.70 |
Gm16090 |
predicted gene 16090 |
43150 |
0.11 |
chr18_20625060_20625736 | 49.81 |
Gm16090 |
predicted gene 16090 |
39862 |
0.12 |
chr18_20625915_20626381 | 20.97 |
Gm16090 |
predicted gene 16090 |
39112 |
0.12 |
chr18_20615543_20616002 | 19.05 |
Gm16090 |
predicted gene 16090 |
49488 |
0.1 |
chr8_47004297_47004459 | 10.64 |
Gm45600 |
predicted gene 45600 |
9799 |
0.17 |
chr18_20624320_20624587 | 9.50 |
Gm16090 |
predicted gene 16090 |
40807 |
0.12 |
chr10_81383963_81384933 | 9.05 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
11 |
0.48 |
chr11_17460047_17460676 | 8.05 |
Gm12015 |
predicted gene 12015 |
161942 |
0.03 |
chr8_47003593_47003771 | 7.81 |
Gm45600 |
predicted gene 45600 |
10495 |
0.17 |
chr12_29526481_29526772 | 7.75 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.41 |
chr7_35344847_35345230 | 7.05 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
10708 |
0.14 |
chr1_85279771_85280739 | 6.96 |
Gm16026 |
predicted pseudogene 16026 |
5148 |
0.14 |
chr18_20618481_20618693 | 6.95 |
Gm16090 |
predicted gene 16090 |
46673 |
0.11 |
chr17_23586174_23586500 | 6.92 |
Zfp13 |
zinc finger protein 13 |
105 |
0.91 |
chr18_20627927_20628180 | 6.89 |
Gm16090 |
predicted gene 16090 |
37207 |
0.12 |
chr13_57603228_57603418 | 6.69 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
304264 |
0.01 |
chr8_47003974_47004154 | 6.62 |
Gm45600 |
predicted gene 45600 |
10113 |
0.17 |
chr2_127521161_127522051 | 6.59 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr12_71601536_71601687 | 6.35 |
9630002D21Rik |
RIKEN cDNA 9630002D21 gene |
23646 |
0.21 |
chr14_12821852_12822433 | 6.29 |
Cadps |
Ca2+-dependent secretion activator |
903 |
0.65 |
chr11_43548063_43548966 | 5.97 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr4_110050502_110051534 | 5.95 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr2_32625098_32626151 | 5.92 |
Ak1 |
adenylate kinase 1 |
186 |
0.86 |
chr14_19042458_19042951 | 5.91 |
Gm48781 |
predicted gene, 48781 |
480 |
0.71 |
chr8_47003312_47003463 | 5.73 |
Gm45600 |
predicted gene 45600 |
10790 |
0.17 |
chr4_87651182_87651681 | 5.70 |
Gm12604 |
predicted gene 12604 |
70642 |
0.13 |
chr11_100527857_100528615 | 5.65 |
Acly |
ATP citrate lyase |
236 |
0.86 |
chr12_5274464_5274897 | 5.53 |
Klhl29 |
kelch-like 29 |
16701 |
0.22 |
chr7_61939801_61940302 | 5.49 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr8_125254170_125254832 | 5.32 |
Gm16237 |
predicted gene 16237 |
27178 |
0.23 |
chr19_22518652_22518803 | 5.32 |
Gm27151 |
predicted gene 27151 |
69862 |
0.11 |
chr18_20626425_20626742 | 5.21 |
Gm16090 |
predicted gene 16090 |
38677 |
0.12 |
chr7_96718538_96719200 | 5.19 |
Tenm4 |
teneurin transmembrane protein 4 |
59065 |
0.11 |
chr16_44632721_44633371 | 5.18 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr9_78880202_78880613 | 5.10 |
Gm47498 |
predicted gene, 47498 |
56376 |
0.1 |
chr5_112213704_112214228 | 5.05 |
Gm26953 |
predicted gene, 26953 |
1495 |
0.29 |
chr6_36818994_36819767 | 5.04 |
Ptn |
pleiotrophin |
9160 |
0.28 |
chr13_28948317_28948483 | 5.04 |
Sox4 |
SRY (sex determining region Y)-box 4 |
5313 |
0.23 |
chr13_93839171_93839651 | 5.02 |
Mir5624 |
microRNA 5624 |
48634 |
0.11 |
chr3_68202202_68202415 | 4.98 |
Gm10292 |
predicted gene 10292 |
130888 |
0.05 |
chr19_59542145_59542347 | 4.97 |
Gm18161 |
predicted gene, 18161 |
1795 |
0.38 |
chrX_143543266_143543620 | 4.92 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr11_92135029_92135209 | 4.90 |
Gm22702 |
predicted gene, 22702 |
110706 |
0.08 |
chr1_76490736_76491111 | 4.87 |
Gm17751 |
predicted gene, 17751 |
1790 |
0.42 |
chr12_86887931_86888776 | 4.79 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
3555 |
0.23 |
chr14_86063145_86063329 | 4.67 |
Gm32729 |
predicted gene, 32729 |
109686 |
0.06 |
chr16_54992065_54992216 | 4.64 |
Gm22977 |
predicted gene, 22977 |
19709 |
0.28 |
chr1_96346717_96347057 | 4.61 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr3_83273897_83274205 | 4.58 |
Gm38096 |
predicted gene, 38096 |
129351 |
0.05 |
chr4_114779259_114779410 | 4.56 |
Gm12830 |
predicted gene 12830 |
42388 |
0.14 |
chr12_7029729_7029880 | 4.55 |
Gm46311 |
predicted gene, 46311 |
62844 |
0.16 |
chr14_34969154_34969501 | 4.53 |
Mir346 |
microRNA 346 |
74718 |
0.11 |
chr12_3238767_3239202 | 4.53 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr7_126288627_126288778 | 4.53 |
Sbk1 |
SH3-binding kinase 1 |
2378 |
0.19 |
chr2_49718537_49718899 | 4.46 |
Kif5c |
kinesin family member 5C |
3849 |
0.28 |
chr7_62232164_62232315 | 4.45 |
Gm9801 |
predicted gene 9801 |
22760 |
0.21 |
chr7_66060127_66060635 | 4.45 |
Snrpa1 |
small nuclear ribonucleoprotein polypeptide A' |
43 |
0.96 |
chr6_122491488_122491885 | 4.44 |
Rimklb |
ribosomal modification protein rimK-like family member B |
5181 |
0.14 |
chr10_37250963_37251350 | 4.42 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
12592 |
0.25 |
chr18_20619091_20619258 | 4.42 |
Gm16090 |
predicted gene 16090 |
46086 |
0.11 |
chr14_66319706_66319909 | 4.40 |
Gm41183 |
predicted gene, 41183 |
21422 |
0.13 |
chr7_96832704_96833057 | 4.38 |
Gm44633 |
predicted gene 44633 |
14574 |
0.14 |
chr1_23098558_23098709 | 4.36 |
Ppp1r14bl |
protein phosphatase 1, regulatory inhibitor subunit 14B like |
3620 |
0.31 |
chr9_47071101_47071252 | 4.35 |
Gm4791 |
predicted gene 4791 |
72435 |
0.1 |
chr18_22850734_22850918 | 4.34 |
Nol4 |
nucleolar protein 4 |
72 |
0.99 |
chr12_102468744_102469733 | 4.31 |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
46 |
0.97 |
chr1_161380092_161380398 | 4.31 |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
15164 |
0.21 |
chr14_75455687_75456060 | 4.29 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr3_51095889_51096111 | 4.29 |
Gm38246 |
predicted gene, 38246 |
7660 |
0.2 |
chr6_86051794_86051956 | 4.25 |
Add2 |
adducin 2 (beta) |
373 |
0.79 |
chr9_41578468_41578685 | 4.24 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
918 |
0.39 |
chr17_45873055_45873569 | 4.24 |
4930542M03Rik |
RIKEN cDNA 4930542M03 gene |
8140 |
0.17 |
chr9_102692609_102692931 | 4.23 |
4930533D04Rik |
RIKEN cDNA 4930533D04 gene |
115 |
0.95 |
chr14_14350947_14351733 | 4.21 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr4_126648482_126648847 | 4.18 |
Gm12933 |
predicted gene 12933 |
16590 |
0.13 |
chr11_103721925_103722258 | 4.17 |
Gm11642 |
predicted gene 11642 |
1859 |
0.26 |
chr18_3116148_3116568 | 4.15 |
Vmn1r238 |
vomeronasal 1 receptor, 238 |
7054 |
0.16 |
chr10_81289386_81289717 | 4.14 |
Tjp3 |
tight junction protein 3 |
1664 |
0.13 |
chr15_35758712_35758863 | 4.11 |
Gm18994 |
predicted gene, 18994 |
25183 |
0.15 |
chr10_34316564_34316763 | 4.09 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
2980 |
0.17 |
chr6_47239363_47240145 | 4.09 |
Cntnap2 |
contactin associated protein-like 2 |
4633 |
0.33 |
chr7_25316512_25317661 | 4.09 |
Megf8 |
multiple EGF-like-domains 8 |
78 |
0.94 |
chr16_86838461_86838612 | 4.09 |
Gm25715 |
predicted gene, 25715 |
6934 |
0.21 |
chr1_168046925_168047110 | 4.08 |
Gm20711 |
predicted gene 20711 |
42878 |
0.2 |
chr18_24529850_24530706 | 4.04 |
Rprd1a |
regulation of nuclear pre-mRNA domain containing 1A |
74 |
0.97 |
chr2_109693106_109694421 | 4.04 |
Bdnf |
brain derived neurotrophic factor |
200 |
0.94 |
chr14_22649708_22649874 | 4.04 |
Lrmda |
leucine rich melanocyte differentiation associated |
53278 |
0.15 |
chr3_32817066_32817811 | 4.04 |
Usp13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
108 |
0.97 |
chr12_26802654_26802851 | 4.03 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
32107 |
0.23 |
chr10_21145268_21145562 | 4.01 |
Gm26577 |
predicted gene, 26577 |
321 |
0.81 |
chr14_119857299_119857740 | 4.01 |
4930404K13Rik |
RIKEN cDNA 4930404K13 gene |
58541 |
0.13 |
chr1_182823776_182823944 | 4.00 |
Susd4 |
sushi domain containing 4 |
58965 |
0.11 |
chr1_164590281_164590783 | 3.99 |
D630023O14Rik |
RIKEN cDNA D630023O14 gene |
15077 |
0.17 |
chr6_122495966_122496190 | 3.99 |
Rimklb |
ribosomal modification protein rimK-like family member B |
2683 |
0.18 |
chr19_53449312_53449723 | 3.99 |
Mirt1 |
myocardial infarction associated transcript 1 |
1974 |
0.25 |
chr1_93100941_93101460 | 3.99 |
Kif1a |
kinesin family member 1A |
622 |
0.65 |
chr1_81594178_81594459 | 3.98 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr14_17722808_17722982 | 3.98 |
Gm48320 |
predicted gene, 48320 |
48227 |
0.17 |
chr1_70442796_70442968 | 3.95 |
Gm38272 |
predicted gene, 38272 |
129971 |
0.05 |
chr18_20627203_20627433 | 3.95 |
Gm16090 |
predicted gene 16090 |
37942 |
0.12 |
chr5_135725743_135726117 | 3.94 |
Por |
P450 (cytochrome) oxidoreductase |
202 |
0.89 |
chr12_117257705_117257898 | 3.92 |
Mir153 |
microRNA 153 |
6984 |
0.29 |
chr16_57302914_57303208 | 3.91 |
Tmem30c |
transmembrane protein 30C |
10196 |
0.14 |
chr7_3314248_3314438 | 3.91 |
Prkcg |
protein kinase C, gamma |
8999 |
0.08 |
chr8_40634456_40635069 | 3.89 |
Mtmr7 |
myotubularin related protein 7 |
3 |
0.98 |
chr9_56830372_56830523 | 3.88 |
Odf3l1 |
outer dense fiber of sperm tails 3-like 1 |
21516 |
0.12 |
chr3_51097482_51097714 | 3.86 |
Gm38246 |
predicted gene, 38246 |
6062 |
0.21 |
chr6_119674568_119674747 | 3.85 |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
52552 |
0.15 |
chr15_8605889_8606074 | 3.83 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
37266 |
0.13 |
chr12_105336106_105336602 | 3.82 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
240 |
0.93 |
chr13_29273638_29274140 | 3.82 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr7_6382694_6383817 | 3.82 |
Zfp28 |
zinc finger protein 28 |
40 |
0.94 |
chr1_178856348_178856609 | 3.78 |
Kif26b |
kinesin family member 26B |
58040 |
0.13 |
chr9_41582201_41582428 | 3.77 |
Mir125b-1 |
microRNA 125b-1 |
388 |
0.42 |
chr18_20618066_20618220 | 3.76 |
Gm16090 |
predicted gene 16090 |
47117 |
0.11 |
chr16_90459106_90459640 | 3.76 |
Hunk |
hormonally upregulated Neu-associated kinase |
2524 |
0.3 |
chr11_20112252_20113564 | 3.76 |
Actr2 |
ARP2 actin-related protein 2 |
1 |
0.98 |
chr12_83044975_83045325 | 3.76 |
Rgs6 |
regulator of G-protein signaling 6 |
1840 |
0.38 |
chr1_119051267_119051418 | 3.75 |
Gli2 |
GLI-Kruppel family member GLI2 |
1997 |
0.35 |
chr16_69577439_69577590 | 3.75 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
222867 |
0.02 |
chr8_12328207_12328374 | 3.74 |
Gm33175 |
predicted gene, 33175 |
8810 |
0.16 |
chr4_141048548_141049235 | 3.74 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
4770 |
0.13 |
chr16_46982388_46982568 | 3.74 |
Gm6912 |
predicted gene 6912 |
91720 |
0.1 |
chr1_18308203_18308365 | 3.74 |
Defb41 |
defensin beta 41 |
43146 |
0.14 |
chr7_34596890_34597065 | 3.74 |
Gm44837 |
predicted gene 44837 |
40735 |
0.11 |
chr7_92984793_92985009 | 3.73 |
Gm31663 |
predicted gene, 31663 |
2849 |
0.25 |
chr18_20628591_20628850 | 3.73 |
Gm16090 |
predicted gene 16090 |
36540 |
0.13 |
chr18_20621175_20621448 | 3.72 |
Gm16090 |
predicted gene 16090 |
43949 |
0.11 |
chr13_113917716_113918082 | 3.72 |
Arl15 |
ADP-ribosylation factor-like 15 |
123277 |
0.05 |
chr8_114295236_114295423 | 3.71 |
4933408N05Rik |
RIKEN cDNA 4933408N05 gene |
56150 |
0.14 |
chr5_111922904_111923242 | 3.70 |
Gm42488 |
predicted gene 42488 |
21162 |
0.23 |
chr1_157938110_157938282 | 3.70 |
Gm38256 |
predicted gene, 38256 |
2189 |
0.46 |
chr6_91348397_91348588 | 3.67 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
16579 |
0.16 |
chr10_13108625_13108836 | 3.66 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
4735 |
0.24 |
chr2_109579120_109579313 | 3.65 |
Gm20638 |
predicted gene 20638 |
93950 |
0.07 |
chr13_83720072_83720262 | 3.65 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1214 |
0.37 |
chr18_14844486_14844862 | 3.65 |
Gm21055 |
predicted gene, 21055 |
14006 |
0.21 |
chr2_51066696_51066895 | 3.63 |
Rnd3 |
Rho family GTPase 3 |
82299 |
0.1 |
chr8_96864637_96865011 | 3.62 |
Gm24132 |
predicted gene, 24132 |
208695 |
0.02 |
chr13_84752343_84752734 | 3.62 |
Gm26913 |
predicted gene, 26913 |
61597 |
0.15 |
chr5_77207847_77208140 | 3.61 |
Spink2 |
serine peptidase inhibitor, Kazal type 2 |
3212 |
0.19 |
chr8_54992339_54992525 | 3.61 |
Gm45265 |
predicted gene 45265 |
12853 |
0.14 |
chr3_80913126_80913366 | 3.61 |
Glrb |
glycine receptor, beta subunit |
282 |
0.93 |
chr17_6860510_6860926 | 3.60 |
Mir692-1 |
microRNA 692-1 |
34619 |
0.11 |
chr1_57218512_57218908 | 3.60 |
BC055402 |
cDNA sequence BC055402 |
3717 |
0.29 |
chr2_113828734_113829247 | 3.59 |
Scg5 |
secretogranin V |
131 |
0.96 |
chr8_8232331_8232493 | 3.59 |
A630009H07Rik |
RIKEN cDNA A630009H07 gene |
102665 |
0.06 |
chr16_45722680_45722901 | 3.58 |
Tagln3 |
transgelin 3 |
1818 |
0.27 |
chr13_78191875_78192156 | 3.57 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1572 |
0.29 |
chr9_41834587_41834738 | 3.57 |
Gm35940 |
predicted gene, 35940 |
19058 |
0.15 |
chr4_100776154_100776315 | 3.55 |
Cachd1 |
cache domain containing 1 |
441 |
0.9 |
chr15_45453906_45454087 | 3.55 |
AC099642.1 |
Endogenous retrovirus group K member 10 (ERVK-10) pseudogene |
292545 |
0.01 |
chr13_107767262_107767617 | 3.55 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr1_169485704_169485889 | 3.53 |
Gm5265 |
predicted pseudogene 5265 |
31927 |
0.17 |
chr10_37626746_37626910 | 3.52 |
Gm48172 |
predicted gene, 48172 |
174148 |
0.03 |
chr1_81520769_81521201 | 3.51 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr18_38214552_38214897 | 3.51 |
2010320O07Rik |
RIKEN cDNA 2010320O07 gene |
1020 |
0.39 |
chr4_52643943_52644118 | 3.50 |
Toporsl |
topoisomerase I binding, arginine/serine-rich like |
36824 |
0.18 |
chr12_27076467_27076625 | 3.50 |
Gm9866 |
predicted gene 9866 |
38449 |
0.22 |
chr8_26678010_26678194 | 3.47 |
Gm32098 |
predicted gene, 32098 |
9796 |
0.18 |
chr11_32002527_32003111 | 3.47 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr5_89883765_89884131 | 3.47 |
Adamts3 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
614 |
0.82 |
chr12_80061788_80062584 | 3.47 |
Gm36660 |
predicted gene, 36660 |
19248 |
0.14 |
chr4_140070081_140070517 | 3.47 |
Gm13027 |
predicted gene 13027 |
61578 |
0.1 |
chr7_48803519_48803712 | 3.46 |
Gm45041 |
predicted gene 45041 |
7313 |
0.16 |
chr1_132211975_132212170 | 3.44 |
Lemd1 |
LEM domain containing 1 |
8220 |
0.12 |
chr10_78727029_78727441 | 3.43 |
Casp14 |
caspase 14 |
8941 |
0.11 |
chr3_105530220_105530411 | 3.43 |
Gm43847 |
predicted gene 43847 |
27408 |
0.18 |
chr9_82812387_82812538 | 3.43 |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
17078 |
0.25 |
chr9_14031471_14031650 | 3.43 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
58060 |
0.11 |
chr6_47231711_47231866 | 3.43 |
Cntnap2 |
contactin associated protein-like 2 |
12599 |
0.29 |
chr10_91858784_91859239 | 3.43 |
Gm31592 |
predicted gene, 31592 |
29818 |
0.24 |
chr14_100374770_100375216 | 3.41 |
Gm26367 |
predicted gene, 26367 |
43490 |
0.15 |
chr16_95596975_95597306 | 3.41 |
Erg |
ETS transcription factor |
10547 |
0.27 |
chr18_20626775_20626931 | 3.40 |
Gm16090 |
predicted gene 16090 |
38407 |
0.12 |
chr17_72194935_72195301 | 3.40 |
Gm19183 |
predicted gene, 19183 |
61140 |
0.15 |
chr16_32156836_32156987 | 3.39 |
Nrros |
negative regulator of reactive oxygen species |
8546 |
0.12 |
chr2_93957285_93957562 | 3.39 |
Gm13889 |
predicted gene 13889 |
222 |
0.91 |
chr13_94575931_94576376 | 3.39 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
33850 |
0.14 |
chr14_75876392_75876718 | 3.39 |
Snora31 |
small nucleolar RNA, H/ACA box 31 |
28650 |
0.12 |
chr14_68361503_68361660 | 3.39 |
Gm31227 |
predicted gene, 31227 |
100050 |
0.07 |
chr3_90606271_90606454 | 3.39 |
S100a4 |
S100 calcium binding protein A4 |
1451 |
0.18 |
chr15_58190488_58190639 | 3.38 |
Gm15943 |
predicted gene 15943 |
23912 |
0.12 |
chr19_59457383_59457662 | 3.38 |
Emx2 |
empty spiracles homeobox 2 |
850 |
0.44 |
chr12_17753065_17753234 | 3.37 |
Hpcal1 |
hippocalcin-like 1 |
24923 |
0.19 |
chr7_99267195_99268129 | 3.37 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chr4_13743823_13743979 | 3.37 |
Runx1t1 |
RUNX1 translocation partner 1 |
465 |
0.89 |
chr10_78464271_78465733 | 3.37 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr10_98354561_98354717 | 3.37 |
Gm8633 |
predicted gene 8633 |
2765 |
0.36 |
chr3_123811268_123811432 | 3.37 |
Gm15400 |
predicted gene 15400 |
50023 |
0.14 |
chr7_79504714_79505014 | 3.36 |
Mir9-3 |
microRNA 9-3 |
400 |
0.7 |
chr13_67451013_67451769 | 3.36 |
Zfp874a |
zinc finger protein 874a |
189 |
0.57 |
chr9_40320937_40321820 | 3.36 |
Gramd1b |
GRAM domain containing 1B |
458 |
0.69 |
chr3_99938984_99939135 | 3.36 |
Spag17 |
sperm associated antigen 17 |
53642 |
0.14 |
chr9_41805841_41806047 | 3.36 |
AC160966.1 |
novel transcript |
261 |
0.72 |
chr10_23718242_23718393 | 3.36 |
Snora33 |
small nucleolar RNA, H/ACA box 33 |
67158 |
0.07 |
chr10_95618546_95618735 | 3.35 |
Gm33336 |
predicted gene, 33336 |
13599 |
0.13 |
chr2_73573013_73573289 | 3.35 |
Chrna1 |
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) |
7187 |
0.15 |
chr9_23062142_23062343 | 3.34 |
Bmper |
BMP-binding endothelial regulator |
160834 |
0.04 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 29.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
4.2 | 21.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
2.5 | 10.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.4 | 2.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.0 | 6.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.0 | 5.9 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.9 | 5.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.7 | 5.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.5 | 4.4 | GO:0060166 | olfactory pit development(GO:0060166) |
1.4 | 5.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.4 | 4.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.3 | 6.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.2 | 3.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 3.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.2 | 2.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.2 | 4.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.2 | 3.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 3.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.2 | 4.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.1 | 3.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.1 | 4.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.1 | 3.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 4.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.1 | 3.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.1 | 3.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.0 | 7.3 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
1.0 | 3.1 | GO:0021564 | vagus nerve development(GO:0021564) |
1.0 | 5.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 0.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.9 | 3.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.9 | 5.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 4.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 2.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 2.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.9 | 6.0 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.8 | 2.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.8 | 4.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.8 | 2.5 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.8 | 2.5 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 2.4 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.8 | 2.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 1.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 1.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.7 | 2.2 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.7 | 3.0 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 5.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.7 | 1.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.7 | 3.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 0.7 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.7 | 5.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 8.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.7 | 1.4 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.7 | 2.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 2.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.7 | 0.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.7 | 2.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.6 | 1.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 3.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 1.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 1.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.8 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 3.6 | GO:0031223 | auditory behavior(GO:0031223) |
0.6 | 3.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 1.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.6 | 1.2 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.6 | 1.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 3.5 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.6 | 1.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.6 | 2.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 2.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.6 | 0.6 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.6 | 4.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.5 | 1.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 0.5 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.5 | 47.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 1.6 | GO:0046959 | habituation(GO:0046959) |
0.5 | 2.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 1.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.5 | 2.1 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 1.0 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 7.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 1.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 2.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 1.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 1.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 1.5 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.5 | 1.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 1.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 3.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 1.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 1.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 2.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.5 | 1.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.5 | 1.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 0.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 2.3 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 1.4 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 0.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 | 1.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 7.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 1.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.5 | 1.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 2.7 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 5.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.4 | 4.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 0.9 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.4 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 1.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 1.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 1.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 1.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 1.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 1.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 1.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.8 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.4 | 0.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 1.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 1.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 2.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 1.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.4 | 3.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.2 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 0.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 0.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.4 | 1.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 0.4 | GO:0097168 | condensed mesenchymal cell proliferation(GO:0072137) mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 0.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 1.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 3.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 1.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 1.9 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.7 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 1.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 8.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.4 | 0.7 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.4 | 1.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 1.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.4 | 1.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 1.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 1.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 0.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.3 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.3 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 0.7 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 1.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.7 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.3 | 1.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 2.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 2.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.3 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.3 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 1.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 0.3 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 2.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.3 | 5.4 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 5.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 1.8 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 1.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 2.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 0.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 2.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 1.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 1.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 2.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.3 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 0.8 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.3 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.3 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 1.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.3 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 12.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.3 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.3 | 1.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.5 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.3 | 2.1 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.3 | 0.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 1.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.3 | 0.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.8 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 0.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 3.8 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 1.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.3 | 1.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 1.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 0.7 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 3.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.7 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.7 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.2 | 1.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 1.7 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.7 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 1.6 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 2.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 1.1 | GO:0072044 | collecting duct development(GO:0072044) |
0.2 | 0.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 2.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.7 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 0.4 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 3.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.4 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 1.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.4 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.2 | 0.6 | GO:0034447 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 1.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.2 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) |
0.2 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.6 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.2 | 1.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 2.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 1.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 3.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 1.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 2.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.2 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 2.1 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 1.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 0.3 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.2 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.2 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.3 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 0.6 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 1.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.8 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.2 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.2 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.5 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.4 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.1 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.1 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.1 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.1 | GO:0048382 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) mesendoderm development(GO:0048382) |
0.1 | 1.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.5 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 1.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 3.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 2.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.6 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 1.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 4.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.4 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.1 | 0.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.7 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 1.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.2 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 1.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.4 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.1 | 0.6 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.1 | 0.3 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.5 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.7 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.2 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.9 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.2 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.8 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 1.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 1.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.1 | 0.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.9 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 1.4 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 1.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 1.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.6 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.2 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.8 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 3.4 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 1.7 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.5 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 1.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 1.2 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.1 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.0 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.0 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.1 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.0 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.5 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.0 | 0.2 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 1.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.0 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.8 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.0 | 1.1 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.3 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.4 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.0 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.2 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0005914 | spot adherens junction(GO:0005914) |
1.8 | 38.3 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 11.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 2.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.8 | 0.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.7 | 8.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 2.6 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 2.6 | GO:0044308 | axonal spine(GO:0044308) |
0.6 | 1.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 1.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 4.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 2.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 5.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 3.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 4.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 5.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 3.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 3.9 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 2.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 2.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 2.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 3.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 1.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 1.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 3.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 1.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 9.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 1.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 3.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 5.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 0.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 2.3 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 1.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 1.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 2.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.3 | 6.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 2.9 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 3.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 8.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 5.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 2.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 1.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 2.3 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 3.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 33.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 9.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 1.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 4.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 3.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 19.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 3.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 6.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 2.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 3.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 33.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.3 | 2.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.3 | 6.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.3 | 3.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.2 | 3.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 3.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 5.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.1 | 3.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 1.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.0 | 3.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.9 | 3.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 4.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 3.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 2.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.8 | 2.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 3.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 2.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 3.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 1.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 6.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.7 | 4.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 2.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 8.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 3.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.7 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 3.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.7 | 9.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 2.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 1.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 2.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 15.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 2.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.6 | 3.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 1.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 4.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 3.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 1.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 2.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 2.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 4.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 2.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 5.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 2.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 2.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.4 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 11.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 1.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.3 | 1.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 1.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 0.9 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 5.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 6.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 2.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.1 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.3 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.5 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 1.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 1.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 10.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 5.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 5.0 | GO:0043813 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) transmembrane receptor protein phosphatase activity(GO:0019198) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.2 | 1.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 1.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 0.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.5 | GO:0018594 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 2.3 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 4.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 3.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.2 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 1.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 5.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 7.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 1.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 1.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 2.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 5.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 2.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 2.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 7.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 2.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 2.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 2.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 2.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 11.7 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 2.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 2.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.4 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 2.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 5.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0018501 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 5.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 4.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 10.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 7.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 9.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 1.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 4.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 5.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 4.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 17.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 2.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 11.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 3.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 33.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.4 | 30.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.9 | 13.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 9.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 5.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 15.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 13.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 7.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 2.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 5.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 5.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 6.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 9.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 6.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 4.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 2.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 2.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 5.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 3.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.9 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |